Cargando…
Metronomic therapy using Methotrexate and Celecoxib: A Boon for Oral Cancer patients during COVID-19 Pandemic
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584917/ https://www.ncbi.nlm.nih.gov/pubmed/33144057 http://dx.doi.org/10.1016/j.oraloncology.2020.105069 |
| _version_ | 1783599682421784576 |
|---|---|
| author | Imaduddin, Mohammed Sultania, Mahesh Vigneshwaran, B. Muduly, Dillip Kumar Kar, Madhabananda |
| author_facet | Imaduddin, Mohammed Sultania, Mahesh Vigneshwaran, B. Muduly, Dillip Kumar Kar, Madhabananda |
| author_sort | Imaduddin, Mohammed |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7584917 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75849172020-10-26 Metronomic therapy using Methotrexate and Celecoxib: A Boon for Oral Cancer patients during COVID-19 Pandemic Imaduddin, Mohammed Sultania, Mahesh Vigneshwaran, B. Muduly, Dillip Kumar Kar, Madhabananda Oral Oncol Letter to the Editor Elsevier Ltd. 2021-03 2020-10-24 /pmc/articles/PMC7584917/ /pubmed/33144057 http://dx.doi.org/10.1016/j.oraloncology.2020.105069 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Imaduddin, Mohammed Sultania, Mahesh Vigneshwaran, B. Muduly, Dillip Kumar Kar, Madhabananda Metronomic therapy using Methotrexate and Celecoxib: A Boon for Oral Cancer patients during COVID-19 Pandemic |
| title | Metronomic therapy using Methotrexate and Celecoxib: A Boon for Oral Cancer patients during COVID-19 Pandemic |
| title_full | Metronomic therapy using Methotrexate and Celecoxib: A Boon for Oral Cancer patients during COVID-19 Pandemic |
| title_fullStr | Metronomic therapy using Methotrexate and Celecoxib: A Boon for Oral Cancer patients during COVID-19 Pandemic |
| title_full_unstemmed | Metronomic therapy using Methotrexate and Celecoxib: A Boon for Oral Cancer patients during COVID-19 Pandemic |
| title_short | Metronomic therapy using Methotrexate and Celecoxib: A Boon for Oral Cancer patients during COVID-19 Pandemic |
| title_sort | metronomic therapy using methotrexate and celecoxib: a boon for oral cancer patients during covid-19 pandemic |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584917/ https://www.ncbi.nlm.nih.gov/pubmed/33144057 http://dx.doi.org/10.1016/j.oraloncology.2020.105069 |
| work_keys_str_mv | AT imaduddinmohammed metronomictherapyusingmethotrexateandcelecoxibaboonfororalcancerpatientsduringcovid19pandemic AT sultaniamahesh metronomictherapyusingmethotrexateandcelecoxibaboonfororalcancerpatientsduringcovid19pandemic AT vigneshwaranb metronomictherapyusingmethotrexateandcelecoxibaboonfororalcancerpatientsduringcovid19pandemic AT mudulydillipkumar metronomictherapyusingmethotrexateandcelecoxibaboonfororalcancerpatientsduringcovid19pandemic AT karmadhabananda metronomictherapyusingmethotrexateandcelecoxibaboonfororalcancerpatientsduringcovid19pandemic |